Abate As Indust

  • Market Cap: Micro Cap
  • Industry: Hospital
  • ISIN: INE454E01013
  • NSEID:
  • BSEID: 531658
INR
10.34
-0.08 (-0.77%)
BSENSE

Jun 19, 03:30 PM

BSE+NSE Vol: 19.84 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

19.84 k (-57.93%) Volume

Shareholding (Mar 2026)

FII

0.00%

Held by 0 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

32.42%

Why is Abate As Industries Ltd falling/rising?

19-Jun-2026

As of 19-Jun, Abate As Industries Ltd's stock price is currently at 10.34, reflecting a decline of 0.77%. The stock has significantly underperformed against the Sensex, with a year-to-date drop of 40.91% compared to the Sensex's decrease of 9.88%.

As of 19-Jun, Abate As Industries Ltd's stock price is falling, currently at 10.34, which reflects a change of -0.08 or -0.77%. The stock has underperformed compared to the benchmark Sensex, which has risen by 1.69% over the past week, while Abate As Industries Ltd has decreased by 1.71%. Additionally, the stock's performance over the past month shows a slight decline of 0.29%, contrasting with the Sensex's gain of 2.13%. Year-to-date, the stock has significantly underperformed, with a drop of 40.91%, while the Sensex has only decreased by 9.88%. <BR><BR>Despite some positive indicators, such as a notable increase in delivery volume by 208.95% on June 17, the stock remains below several moving averages, indicating a weaker short-term performance compared to longer-term trends. Overall, these factors contribute to the current decline in the stock price of Abate As Industries Ltd.

View full answer

How big is Abate As Indust?

11-Jun-2026

As of 10th June, Abate As Industries Ltd has a market capitalization of 167.00 Cr, with recent net sales of 159.82 Cr and a net profit of 12.31 Cr over the last four quarters.

As of 10th June, <BR><BR>Market Cap: Abate As Industries Ltd has a market capitalization of 167.00 Cr and is classified as a Micro Cap.<BR><BR>Recent Quarterly Performance: The sum of Net Sales for the latest 4 quarters is 159.82 Cr, while the sum of Net Profit for the same period is 12.31 Cr.<BR><BR>Balance Sheet Snapshot: The reporting period for the balance sheet is March 2025. Shareholder's Funds are valued at 163.79 Cr, and Total Assets amount to 205.47 Cr.

View full answer

Who are in the management team of Abate As Indust?

11-Jun-2026

The management team of Abate As Indust includes Kamlesh B Mehta (Executive Director), Visswas B Panse (Independent Non-Executive Director), and Ashok Bhanushali (Non-Executive Director).

The management team of Abate As Indust includes the following individuals:<BR><BR>1. **Kamlesh B Mehta** - Executive Director<BR>2. **Visswas B Panse** - Independent Non-Executive Director<BR>3. **Ashok Bhanushali** - Non-Executive Director<BR><BR>If you need more information about their roles or the company, feel free to ask!

View full answer

Who are the peers of the Abate As Indust?

11-Jun-2026

Abate As Indust's peers include Lotus Eye Hospital, Aashka Hospitals, Fortis Malar, KHFM Hospitality, Vaidya Sane, Nephro Care, Maitreya Medica, Aprameya Engineering, and Sangani Hospital. Management risks vary from below average to average, with Nephro Care showing excellent growth, while 1-year returns range from Lotus Eye Hospital's 66.04% to Aashka Hospitals' -24.05%.

Peers: The peers of Abate As Indust are Lotus Eye Hospit, Aashka Hospitals, Fortis Malar, KHFM Hospitality, Vaidya Sane, Nephro Care, Maitreya Medica., Aprameya Enginee, and Sangani Hospital.<BR><BR>Quality Snapshot: Below Average management risk is observed at Lotus Eye Hospit, Aashka Hospitals, Fortis Malar, KHFM Hospitality, Maitreya Medica., and Sangani Hospital, while Average management risk is found at Vaidya Sane and Nephro Care. Growth is Excellent at Nephro Care, Average at Vaidya Sane, and Below Average at Lotus Eye Hospit, Aashka Hospitals, Fortis Malar, KHFM Hospitality, Maitreya Medica., Aprameya Enginee, and Sangani Hospital. Capital Structure is Good at Lotus Eye Hospit, Vaidya Sane, and Aprameya Enginee, Average at Aashka Hospitals and Abate As Indust, and Below Average at Fortis Malar, KHFM Hospitality, Maitreya Medica., Nephro Care, and Sangani Hospital.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Lotus Eye Hospit at 66.04%, while Aashka Hospitals has the lowest at -24.05%. Abate As Indust's 1-year return is 2.50%, which is higher than Aashka Hospitals but significantly lower than Lotus Eye Hospit. Additionally, Fortis Malar, KHFM Hospitality, and Maitreya Medica. have negative six-month returns.

View full answer

What does Abate As Indust do?

10-Jun-2026

Abate As Industries Ltd, a micro-cap company in the hospital industry, reported net sales of 34 Cr and a net profit of 3 Cr for the quarter ending March 2026. The company, formerly known as Trijal Industries Limited, has a market cap of INR 167 Cr and a P/E ratio of 13.00.

Overview: <BR>Abate As Industries Ltd operates in the hospital industry and is categorized as a micro-cap company.<BR><BR>History: <BR>The company was incorporated on 26th June 1991 and was originally known as Trijal Industries Limited. It changed its name to Abate As Industries Limited on 21st October 2021. The most recent quarterly results reported net sales and net profit for the period ending March 2026.<BR><BR>Financial Snapshot: <BR>Net Sales: 34 Cr (Quarterly Results - Mar 2026) <BR>Net Profit: 3 Cr (Quarterly Results - Mar 2026) <BR>Market Cap: INR 167 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 13.00 <BR>Industry P/E: 21 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 0.03 <BR>Return on Equity: 7.09% <BR>Price to Book: 0.97 <BR><BR>Contact Details: <BR>Address: Siddhart Nagar No 5 S V Road, Chawl 19/168 Goregaon West Mumbai Maharashtra : 400062 <BR>Email: k4kamleshm@yahoo.com <BR>Website: http://www.abateas.com

View full answer

Should I buy, sell or hold Abate As Industries Ltd?

31-May-2026

When is the next results date for Abate As Industries Ltd?

26-May-2026

The next results date for Abate As Industries Ltd is 29 May 2026.

The next results date for Abate As Industries Ltd is scheduled for 29 May 2026.

View full answer

Are Abate As Industries Ltd latest results good or bad?

13-Feb-2026

Abate As Industries Ltd's latest results are concerning, with a 24.82% decline in net profit to ₹3.06 crore despite a slight revenue increase of 1.33% to ₹42.69 crore. While operational efficiency improved, the significant drop in other income and overall profitability raises red flags about the company's financial health.

Abate As Industries Ltd's latest results present a mixed picture. In Q3 FY26, the company reported a net profit of ₹3.06 crore, which is a significant decline of 24.82% compared to the previous quarter's profit of ₹4.07 crore. This drop in net profit raises concerns about the sustainability of its profitability, especially following the extraordinary growth of 80.89% in the prior quarter.<BR><BR>On the positive side, the company's revenue for the quarter was ₹42.69 crore, reflecting a modest growth of 1.33% from ₹42.13 crore in Q2 FY26. This indicates that while the company is maintaining a solid revenue run rate, the growth momentum has slowed considerably compared to previous quarters.<BR><BR>Additionally, the operating margin improved to 9.23%, the highest in four quarters, which suggests some operational efficiency gains. However, the net profit margin contracted to 7.17%, primarily due to a sharp decline in other income, which fell by nearly 95% from the previous quarter.<BR><BR>Overall, while Abate As Industries has shown some operational improvements, the decline in net profit and the volatility in other income raise red flags about its financial health. The stock has also experienced significant volatility, trading 47% below its 52-week high, which reflects investor uncertainty. Therefore, the results can be viewed as concerning, particularly regarding profitability and valuation sustainability.

View full answer

How has been the historical performance of Abate As Indust?

17-Nov-2025

Abate As Indust reported an operating income of 14.09 Cr and a profit after tax of 1.11 Cr for the year ending March 2025, with an EPS of 0.07 and strong profit margins of 5.25% and 7.81%. The company has total liabilities of 205.47 Cr and shareholder's funds of 163.79 Cr, indicating a solid financial position.

Answer:<BR>The historical performance of Abate As Indust shows a total operating income of 14.09 Cr for the year ending March 2025, with a total expenditure of 13.35 Cr, resulting in an operating profit (PBDIT) of 1.71 Cr. After accounting for interest and depreciation, the profit before tax stands at 1.10 Cr, leading to a profit after tax of 1.11 Cr. The earnings per share (EPS) for the same period is reported at 0.07. The company maintains a strong operating profit margin of 5.25% and a profit after tax margin of 7.81%. <BR><BR>Breakdown:<BR>Abate As Indust reported a total operating income of 14.09 Cr, with raw material costs and other operating expenses contributing to a total expenditure of 13.35 Cr. This resulted in an operating profit of 1.71 Cr, which, after deducting interest and depreciation, led to a profit before tax of 1.10 Cr and a profit after tax of 1.11 Cr. The company’s earnings per share is 0.07, reflecting its profitability. The operating profit margin is 5.25%, while the profit after tax margin is notably higher at 7.81%. On the balance sheet, total liabilities amount to 205.47 Cr, with shareholder's funds at 163.79 Cr, indicating a solid financial foundation. The cash flow from financing activities shows a net inflow of 164.00 Cr, contributing to a closing cash equivalent of 1.00 Cr.

View full answer

Is Abate As Indust overvalued or undervalued?

18-Jul-2025

As of July 17, 2025, Abate As Indust is considered very expensive and overvalued, with a PE ratio of 321.59, significantly higher than its peers, and a recent stock performance of 111.65% compared to the Sensex's 0.83%.

As of 17 July 2025, the valuation grade for Abate As Indust has moved from does not qualify to very expensive, indicating a significant shift in its perceived value. The company is currently considered overvalued. Key ratios include a PE ratio of 321.59, an EV to EBIT of 362.63, and an ROE of 0.67%. <BR><BR>In comparison to its peers, Abate As Indust's valuation metrics are starkly high; for instance, Elitecon International has a PE ratio of 273.4, while Lloyds Enterprises stands at 178.83. This suggests that Abate As Indust is priced at a premium compared to its competitors. Additionally, the company's recent stock performance has outpaced the Sensex, with a 1-month return of 111.65% compared to the Sensex's 0.83%, reinforcing the notion of an inflated valuation.

View full answer

Who are the top shareholders of the Abate As Indust?

17-Jul-2025

The top shareholders of Abate As Indust are the Al Salama Eye Research Foundation with 12.75%, followed by Kanta Devi Samdaria at 2.39%, while individual investors hold a combined 58.46%. There are no institutional holdings from mutual funds or foreign investors.

The top shareholders of Abate As Indust include the Al Salama Eye Research Foundation, which holds the largest stake at 12.75%. The highest public shareholder is Kanta Devi Samdaria, with a holding of 2.39%. Additionally, individual investors collectively hold a significant portion of 58.46%. There are no institutional holdings from mutual funds or foreign institutional investors.

View full answer

What is the technical trend for Abate As Indust?

09-Jun-2025

As of May 19, 2025, Abate As Indust shows a mildly bearish trend due to daily moving averages and weekly RSI indicating bearish momentum, despite mixed signals from other indicators.

As of 19 May 2025, the technical trend for Abate As Indust has changed from does not qualify to mildly bearish. The current stance is mildly bearish, driven primarily by the daily moving averages indicating a bearish trend and the weekly RSI showing bearish momentum. While the weekly MACD and Bollinger Bands are mildly bullish, the monthly indicators remain bearish, suggesting a lack of strong upward momentum. The Dow Theory indicates no trend on the weekly timeframe, but mildly bullish on the monthly, adding to the mixed signals. Overall, the strength of the bearish stance is supported by the daily moving averages and the weekly RSI.

View full answer
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

With a Operating Losses, the company has a Weak Long Term Fundamental Strength

  • The company has been able to generate a Return on Equity (avg) of 3.88% signifying low profitability per unit of shareholders funds
2

Below par performance in long term as well as near term

stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Hospital

stock-summary
Market cap

INR 164 Cr (Micro Cap)

stock-summary
P/E

13.00

stock-summary
Industry P/E

23

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.03

stock-summary
Return on Equity

7.09%

stock-summary
Price to Book

0.95

Revenue and Profits:
Net Sales:
34 Cr
(Quarterly Results - Mar 2026)
Net Profit:
3 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-10.79%
0%
-10.79%
6 Months
-37.71%
0%
-37.71%
1 Year
-2.5%
0%
-2.5%
2 Years
-27.94%
0%
-27.94%
3 Years
11.66%
0%
11.66%
4 Years
101.17%
0%
101.17%
5 Years
0%
0%
0.0%

Abate As Indust for the last several years.

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

News

Announcements stock-summary

Response To BSE Query Regarding Auditors Report.

11-Jun-2026 | Source : BSE

Submission of detailed Independent Auditors Report in response to BSE query dated 11th June 2026.

Announcement under Regulation 30 (LODR)-Earnings Call Transcript

04-Jun-2026 | Source : BSE

Announcement under Regulation 30 (LODR)- Earning Call Transcript

Announcement under Regulation 30 (LODR)-Newspaper Publication

01-Jun-2026 | Source : BSE

Submission of Newspaper Publication of Standalone and Consolidated Financial Results for the Quarter and Year Ended 31st March 2026.

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

Abate As Industries Ltd has announced 1:1 bonus issue, ex-date: 31 Jul 25

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
0.00%
EBIT Growth (5y)
-14.00%
EBIT to Interest (avg)
5.57
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.03
Sales to Capital Employed (avg)
0.08
Tax Ratio
5.67%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
-28.62%
ROE (avg)
3.88%

Valuation key factors

Factor
Value
P/E Ratio
13
Industry P/E
23
Price to Book Value
0.95
EV to EBIT
15.53
EV to EBITDA
13.09
EV to Capital Employed
0.95
EV to Sales
1.07
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
6.10%
ROE (Latest)
7.09%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Halik Musthafa K . (4.81%)

Highest Public shareholder

Shireen M T (14.62%)

Individual Investors Holdings

13.87%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 0.00% vs 0.00% in Dec 2025",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -10.71% vs -66.67% in Dec 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.11",
          "val2": "-0.09",
          "chgp": "-22.22%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "0.25",
          "val2": "0.28",
          "chgp": "-10.71%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2025 is 0.00% vs 0.00% in Sep 2024",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2025 is 1,733.33% vs 40.00% in Sep 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.37",
          "val2": "-0.06",
          "chgp": "-516.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "0.98",
          "val2": "-0.06",
          "chgp": "1,733.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is 0.00% vs 0.00% in Dec 2024",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is 3,250.00% vs 66.67% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.46",
          "val2": "-0.04",
          "chgp": "-1,050.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "1.26",
          "val2": "-0.04",
          "chgp": "3,250.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2026 is 0.00% vs 0.00% in Mar 2025",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2026 is 187.04% vs 159.34% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.57",
          "val2": "-0.43",
          "chgp": "-32.56%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "1.55",
          "val2": "0.54",
          "chgp": "187.04%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Standalone) - Mar'26 - QoQstock-summary

Mar'26
Dec'25
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-0.11
-0.09
-22.22%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Standalone Net Profit
0.25
0.28
-10.71%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
Values in Rs Cr.
Net Sales

QoQ Growth in quarter ended Mar 2026 is 0.00% vs 0.00% in Dec 2025

Direction Arrows
Standalone Net Profit

QoQ Growth in quarter ended Mar 2026 is -10.71% vs -66.67% in Dec 2025

Half Yearly Results Snapshot (Standalone) - Sep'25stock-summary

Sep'25
Sep'24
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-0.37
-0.06
-516.67%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Standalone Net Profit
0.98
-0.06
1,733.33%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
Values in Rs Cr.
Net Sales

Growth in half year ended Sep 2025 is 0.00% vs 0.00% in Sep 2024

Direction Arrows
Standalone Net Profit

Growth in half year ended Sep 2025 is 1,733.33% vs 40.00% in Sep 2024

Nine Monthly Results Snapshot (Standalone) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-0.46
-0.04
-1,050.00%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Standalone Net Profit
1.26
-0.04
3,250.00%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
Values in Rs Cr.
Net Sales

YoY Growth in nine months ended Dec 2025 is 0.00% vs 0.00% in Dec 2024

Direction Arrows
Standalone Net Profit

YoY Growth in nine months ended Dec 2025 is 3,250.00% vs 66.67% in Dec 2024

Annual Results Snapshot (Standalone) - Mar'26stock-summary

Mar'26
Mar'25
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-0.57
-0.43
-32.56%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Standalone Net Profit
1.55
0.54
187.04%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
Values in Rs Cr.
Net Sales

YoY Growth in year ended Mar 2026 is 0.00% vs 0.00% in Mar 2025

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2026 is 187.04% vs 159.34% in Mar 2025

stock-summaryCompany CV
About Abate As Industries Ltd stock-summary
stock-summary
Abate As Industries Ltd
Micro Cap
Hospital
Abate As Industries Limited, formerly known as Trijal Industries Limited was incorporated on 26th June 1991 and was engaged in the business of trading of goods and Misc Financial and Consultancy activities. The Company changed its name to Abate AS Industries Limited on 21st October 2021. Dr. Adv. A. Samsudeen, the Founder and Chairman of ABATE AS Group of Companies, is a visionary leader and a strong believer in ethical, purpose driven growth.
Company Coordinates stock-summary
Company Details
Siddhart Nagar No 5 S V Road, Chawl 19/168 Goregaon West Mumbai Maharashtra : 400062
stock-summary
Tel:
stock-summary
k4kamleshm@yahoo.com
Registrar Details
Purva Shareregistry (India) Pvt Ltd , Gala No 9, Shiv Shakti, Industrial Estate,Sitaram Mill Comp., J R Boricha Marg, Lower Parel [E], Mumbai